Clinical Trials Browser

Phase NA × Myelodysplastic Syndromes × CPX-351 × Clear all

NCT01804101 2018-05-25

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase NA Completed

48 enrolled 9 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute